Japan Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Indu

Japan Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032

Point-of-care glucose testing involves measurement of blood glucose levels of the patient at the point of care or bedside. It does not include sending blood samples for analysis to the laboratory. It is commonly used in the management of diabetes. Products used for point-of-care glucose testing include strips, lancets and lancing devices, and meters.

The Japan point-of-care glucose testing market is expected to witness substantial growth in the coming years owing to the surge in awareness of diabetes among consumers, government-led initiatives, and enterprises committing to enhancing healthcare across the country.

Further, stringent regulatory requirements for approval of glucose meters and other point-of-care glucose testing devices restrains the growth of the market in Japan.

Technological advancements such as wireless connectivity for glucose testing which helped monitor and maintain a record of the glucose levels without human involvement, attract the customers who are aware of the importance of maintaining a record of the glucose levels, and prefer to do so from the comfort of their home. This increases the demand for such devices, in turn, fostering the growth of the Japan point-of-care glucose testing market.

The Japan point-of-care glucose testing market is segmented on the basis of product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips, and blood-glucose meter. The blood-glucose meter segment is further bifurcated into Lifescan one touch ultra & Lifescan one touch verio; Accuchek Aviva Plus & Accuchek; FreeStyle Lite & FreeStyle precision neo; Contour Next; and others. On the basis of application, the market is classified into type-1 diabetes, and type-2 diabetes. As per end user, it is segregated into hospitals & clinics, home care settings, and others.

Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Siemens Healthcare, Arkray Inc., Otsuka Pharmaceutical Co., FUJIFILM Holdings Corp., ETHICON, Inc., Novo Nordisk A/S and OLYMPUS CORPORATION are some of the major players in the Japan point-of-care glucose testing market. Further, five emerging companies in the market include Bionovate, ARKRAY USA Inc., Diatrics, Ciphergen Biosystems, and LifeScan. Companies in Japan are focusing on partnerships and collaborations to sustain the intense competition in the market.

New product developments, are thus, observed and expected in the Japan point-of-care glucose monitoring market, as the country adopts advanced technologies to manage healthcare facilities. The future of the Japan point-of-care glucose monitoring market is thus marked by integration of technology, stringent regulations, and patient-centric design, which play a pivotal role in shaping its growth in the coming years.

The Japan point-of-care glucose testing market is anticipated to witness growth during the forecast period owing to technological advancements and adoption of IoT or wireless technologies. A lot of people prefer home care settings to monitor their health. To cater the same, a lot of companies are coming up with wireless monitoring devices which enable the patient to monitor the health from home and similarly feed and maintain the data remotely in the laboratory. This also prevents the patients from visiting the laboratory. These is an increase in demand for such devices to monitor glucose levels in Japan as well. This, in turn, fosters the point-of-care glucose testing market growth in Japan.

Key Benefits For Stakeholders

Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.

Analyze the key strategies adopted by major market players in Japan point-of-care glucose testing market.

Assess and rank the top factors that are expected to affect the growth of Japan point-of-care glucose testing market.

Top Player positioning provides a clear understanding of the present position of market players.

Detailed analysis of the Japan point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.

Identify key investment pockets for various offerings in the market.
Product Benchmarking / Product specification and applications
Upcoming/New Entrant by Regions
New Product Development/ Product Matrix of Key Players
Patient/epidemiology data at country, region, global level
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product Type

Lancing Devices and Strips
Blood-Glucose Meter
Type
Lifescan OneTouch Ultra and Lifescan OneTouch Verio
Accu-Chek Aviva Plus and Accuchek
Freestyle Lite and Freestyle Precission Neo
Contour Next
Others

By Application

Type-1 Diabetes
Type-2 Diabetes

By End User

Hospitals and Clinics
Home Care Settings
Others

Key Market Players

Abbott Laboratories
Roche Diagnostics
Sysmex Corporation
Siemens Healthcare
Arkray Inc.
Otsuka Pharmaceutical Co.
FUJIFILM Holdings Corp.
ETHICON, Inc.
Novo Nordisk A/S
OLYMPUS CORPORATION

Please Note: It will take 7-10 business days to complete the report upon order confirmation.